Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

A federal court in Philadelphia will soon evaluate claims against the makers of Ozempic, Wegovy and similar ... after taking these drugs brought lawsuits alleging that these companies failed ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

Many recent developments have taken place in the Mounjaro lawsuits. On August 8 ... Did You Experience Side Effects After Taking Mounjaro, Ozempic or Another Weight Loss Drug?

None of the lawsuits have succeed in stopping the negotiation process so far, though the cases are continuing to wind their way through district and appellate courts. Ozempic, which the US Food ...

Semaglutide has been “extensively” examined in several clinical development programs ... centralized several lawsuits filed against weight loss drugs such as Ozempic and Wegovy.

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs ... The company filed a lawsuit seeking to stop the Medicare negotiation process shortly after ...

In a statement to CBS News about this lawsuit and others ... the drug sold under the Ozempic and Wegovy brand names, has been extensively examined in robust clinical development programs and ...

According to Lawsuit Information Center, as of June 3, there are 101 pending cases in the Ozempic MDL ... extensively examined in robust clinical development programs, large real world evidence ...

Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced ... world evidence studies and robust clinical development programs with a cumulative exposure ...

The Danish company Novo Nordisk makes Ozempic, Wegovy and Rybelsus. The American company Eli Lilly makes Trulicity and Mounjaro. The lawsuit will likely remind people that no drug is free of risk ...